Traditional Chinese Medicine and regulatory reform are driving Rx-to-OTC switch in China, the country's non-prescription medicines industry association says. Furthermore, Alibaba's "new retail" model of blending online and bricks-and-mortar shopping is fostering innovation in the Chinese market, creating opportunities for international OTC players. However, there is still room for improvement, according to the Global Self-Care Federation's recently published Self-Care readiness Index.
Regulatory reform and a strong demand for traditional Chinese medicines (TCM) will help drive Rx-to-OTC switch in China, according to the country’s non-prescription medicines industry association, the CNMA.
“With the improvement of regulations and technical guidelines, it can be anticipated that more and more OTC products will appear